Neurointerventional for Pseudotumor cerebri

N/A

Waitlist Available

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1,3,6,12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new treatment called venous sinus stenting for patients with Increased Intracranial Hypertension (IIH) who don't get better with standard treatments. The stent is a small tube placed in a brain vein to keep it open, which helps lower pressure inside the head. This can improve symptoms like headaches and vision problems. Venous sinus stenting has shown promising results in treating patients with idiopathic intracranial hypertension (IIH) who are refractory to medical treatment.

Eligible Conditions

Pseudotumor cerebri

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1,3,6,12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1,3,6,12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1,3,6,12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Normalized CSF pressure post venous stenting

Secondary study objectives

Assess the long-term success of this treatment in terms of clinical recurrence rate and long-term patency of the sinus.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: NeurointerventionalExperimental Treatment1 Intervention

Stenting of the venous sinus is the neuro-interventional treatment that is being offered to patients with idiopathic intracranial hypertension that are refractory to medical management.

Do I qualify?Apply below to find out